Illumina (ILMN) Restructuring Costs (2012 - 2022)

Illumina (ILMN) reported Restructuring Costs of $609.0 million for Q3 2022, up 145943.17% quarter-over-quarter from $417000.0 in Q1 2017.

Illumina (ILMN) Restructuring Costs (2012 - 2022) Analysis & Trends

Illumina has reported Restructuring Costs for 6 years, with the latest figure at $609.0 million in Q3 2022.

For the quarter ending Q3 2022, Restructuring Costs changed N/A year-over-year to $609.0 million; the trailing twelve-month figure through Jul 2022 stood at $609.8 million (up 55135.69% YoY), and the FY2017 full-year result was $1.5 million, up 156.91% from the prior year.
Restructuring Costs for Q3 2022 stood at $609.0 million, up from $417000.0 in the prior quarter.
The five-year high for Restructuring Costs was $609.0 million in Q3 2022, with the low at $609.0 million in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	30,529.42 Bn	30,528.96 Bn	1.11 Bn
2	Thermo Fisher Scientific	183.75 Bn	180.50 Bn	7.74 Bn
3	Danaher	133.13 Bn	127.43 Bn	3.59 Bn
4	Idexx Laboratories	46.14 Bn	45.94 Bn	722.74 Mn
5	Agilent Technologies	38.20 Bn	36.39 Bn	990.00 Mn
6	Natera	31.50 Bn	30.40 Bn	696.04 Mn
7	Iqvia Holdings	31.34 Bn	29.36 Bn	1.36 Bn
8	Illumina	24.51 Bn	23.36 Bn	721.00 Mn
9	Mettler Toledo International	23.53 Bn	23.47 Bn	555.82 Mn
10	Quest Diagnostics	22.51 Bn	22.42 Bn	942.00 Mn

Download Data